Biomarker News and Research

RSS
A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular marker and signature molecule.
Adeona completes enrollment in Part 2 CopperProof-2 clinical study

Adeona completes enrollment in Part 2 CopperProof-2 clinical study

New biomarker could aid in accurate diagnosis of Alzheimer's disease

New biomarker could aid in accurate diagnosis of Alzheimer's disease

Optical technology shows potential for prescreening patients at high risk for lung cancer

Optical technology shows potential for prescreening patients at high risk for lung cancer

Researchers discover biomarker for allergy can originate from mother

Researchers discover biomarker for allergy can originate from mother

Cancer cells utilize energy-rich intermediates of sugar metabolism: Research

Cancer cells utilize energy-rich intermediates of sugar metabolism: Research

Lixte, NCI collaborate for clinical evaluation of LB-100 compound

Lixte, NCI collaborate for clinical evaluation of LB-100 compound

MRI technique may help predict decline in individuals with mild cognitive impairment

MRI technique may help predict decline in individuals with mild cognitive impairment

Merck Serono to present Erbitux data at ESMO Congress

Merck Serono to present Erbitux data at ESMO Congress

mtDNA deletion: New biomarker for identifying malignant prostate cancer

mtDNA deletion: New biomarker for identifying malignant prostate cancer

Amgen announces PRIME '203' and '181' Phase 3 trial results

Amgen announces PRIME '203' and '181' Phase 3 trial results

Gentel Biosciences, RayBiotech to develop antibody array products with APiX chromogenic detection platform

Gentel Biosciences, RayBiotech to develop antibody array products with APiX chromogenic detection platform

Neuro-Biotech introduces biomarker for progressive clinical investigation on Alzheimer's Disease

Neuro-Biotech introduces biomarker for progressive clinical investigation on Alzheimer's Disease

Reduced levels of brain-derived neurotrophic factor are a trait marker for psychogenic non-epileptic seizures

Reduced levels of brain-derived neurotrophic factor are a trait marker for psychogenic non-epileptic seizures

Aeras Global receives FDA grant to develop biomarkers for TB vaccine

Aeras Global receives FDA grant to develop biomarkers for TB vaccine

NIH awards contract to develop nanotechnology tools for atherosclerosis treatment

NIH awards contract to develop nanotechnology tools for atherosclerosis treatment

New SymPath kit measures DBH activity of Sympathetic Nervous System

New SymPath kit measures DBH activity of Sympathetic Nervous System

AVEO Pharmaceuticals to present tivozanib Phase 2 study results at IKCS Symposium

AVEO Pharmaceuticals to present tivozanib Phase 2 study results at IKCS Symposium

VirtualScopics third-quarter revenues increase 25% to $3.5 million

VirtualScopics third-quarter revenues increase 25% to $3.5 million

Aethlon Medical engages Fabiani & Company to assist in establishment of federal partnerships

Aethlon Medical engages Fabiani & Company to assist in establishment of federal partnerships

Agilent introduces SureSelect Kinome Target Enrichment Kit to focus next-generation sequencing studies

Agilent introduces SureSelect Kinome Target Enrichment Kit to focus next-generation sequencing studies

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.